Cite
HARVARD Citation
McKenzie, A. et al. (2022). A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab. Clinical and translational science. 15 (3), pp. 626-637. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
McKenzie, A. et al. (2022). A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab. Clinical and translational science. 15 (3), pp. 626-637. [Online].